ANTX vs VRTX: Which Stock is Better?

Side-by-side comparison of An2 Therapeutics Inc and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

ANTX

An2 Therapeutics Inc

$2.85

VRTX

Vertex Pharmaceuticals Inc

$456.69

Key Metrics Comparison

MetricANTXVRTXWinner
Market Cap$46.86M$117.05BVRTX
P/E RatioN/A30.12VRTX
EPS (TTM)$N/A$15.30VRTX
Revenue Growth0.0%0.1%VRTX
Gross Margin0.0%53.7%VRTX

Analyze ANTX

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ANTX or VRTX a better investment?

Comparing ANTX and VRTX: An2 Therapeutics Inc has a market cap of $46.86M while Vertex Pharmaceuticals Inc has $117.05B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ANTX and VRTX?

ANTX (An2 Therapeutics Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ANTX or VRTX?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ANTX or VRTX?

VRTX has higher revenue growth at 0.1% vs 0.0% for ANTX.

Which company is more profitable: ANTX or VRTX?

Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 0.0% for ANTX.

Which is the larger company: ANTX or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $117.05B compared to $46.86M for ANTX.

Should I buy ANTX or VRTX in 2026?

Both ANTX and VRTX have investment merit. ANTX trades at $2.85 while VRTX trades at $456.69. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ANTX and VRTX stock?

Key differences: Market Cap ($46.86M vs $117.05B), P/E Ratio (N/A vs 30.1x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 53.7%).

Popular Stock Comparisons